VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 60 filers reported holding VOR BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,343,758 | -31.4% | 633,848 | 0.0% | 0.01% | -27.3% |
| Q2 2023 | $1,958,590 | -42.6% | 633,848 | 0.0% | 0.01% | -42.1% |
| Q1 2023 | $3,410,102 | -65.0% | 633,848 | -56.8% | 0.02% | -67.8% |
| Q4 2022 | $9,748,401 | +67.1% | 1,465,925 | 0.0% | 0.06% | +55.3% |
| Q3 2022 | $5,834,000 | +3.1% | 1,465,925 | +28.7% | 0.04% | +18.8% |
| Q2 2022 | $5,660,000 | – | 1,138,768 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 6,361,723 | $13,486,853 | 3.88% |
| OUP Management Co., LLC | 374,714 | $794,394 | 1.79% |
| RA Capital Management | 22,748,880 | $48,227,626 | 0.95% |
| Paradigm Biocapital Advisors LP | 6,461,467 | $13,698,310 | 0.93% |
| JOHNSON & JOHNSON | 1,074,658 | $2,278,275 | 0.84% |
| Trustees of Columbia University in the City of New York | 91,910 | $194,849 | 0.36% |
| Artal Group S.A. | 2,688,015 | $5,699 | 0.24% |
| Sarissa Capital Management LP | 618,000 | $1,310,160 | 0.18% |
| Laurion Capital Management LP | 3,182,889 | $6,747,724 | 0.04% |
| Woodline Partners LP | 1,111,123 | $2,355,581 | 0.03% |